Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Moritz Mirna

Showing results (41-50 of 57) with videos related to

Pageof 6
Sort By:
Minerva Medica|April 14, 2018
Analysis of novel cardiovascular biomarkers in patients with peripheral artery diseasePeter Jirak, Moritz Mirna, Bernhard Wernly, et al.
Advances in Clinical Chemistry|February 25, 2019
Clinical implications of fetuin-APeter Jirak, Lars Stechemesser, Elena Moré, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|November 2, 2021
The differential diagnostic value of selected cardiovascular biomarkers in Takotsubo syndromeAlbert Topf, Moritz Mirna, Vera Paar, et al.
European Journal of Internal Medicine|November 16, 2020
Serum levels of C-terminal FGF23 (cFGF23) are associated with 1-year-mortality in patients undergoing transcatheter aortic valve replacement (TAVR)Moritz Mirna, Alexander Lauten, Peter Jirak, et al.
Cardiovascular Research|January 23, 2021
A new player in the game: treatment with antagomiR-21a-5p significantly attenuates histological and echocardiographic effects of experimental autoimmune myocarditisMoritz Mirna, Vera Paar, Albert Topf, et al.
Panminerva Medica|April 21, 2020
Novel cardiovascular biomarkers in patients with cardiovascular diseases undergoing intensive physical exerciseMoritz Mirna, Michael Lichtenauer, Bernhard Wernly, et al.
Cells|November 11, 2022
Cell-Free Double-Stranded DNA to DNase Ratio Predicts Outcome after Primary Survived Cardiac ArrestRichard Rezar, Michael Lichtenauer, Vera Paar, et al.
Cells|October 13, 2023
MicroRNA-30d-5p-A Potential New Therapeutic Target for Prevention of Ischemic Cardiomyopathy after Myocardial InfarctionElke Boxhammer, Vera Paar, Bernhard Wernly, et al.
Frontiers in Medicine|February 21, 2022
Dexamethasone Improves Cardiovascular Outcomes in Critically Ill COVID-19, a Real World Scenario Multicenter AnalysisPeter Jirak, Vincent van Almsick, Dimitrios Dimitroulis, et al.
Frontiers in Cardiovascular Medicine|December 13, 2021
Higher Incidence of Stroke in Severe COVID-19 Is Not Associated With a Higher Burden of Arrhythmias: Comparison With Other Types of Severe PneumoniaPeter Jirak, Zornitsa Shomanova, Robert Larbig, et al.
Pageof 6

Showing results (41-50 of 57) with videos related to

Sort By:
Pageof 6
Minerva Medica|April 14, 2018
Analysis of novel cardiovascular biomarkers in patients with peripheral artery diseasePeter Jirak, Moritz Mirna, Bernhard Wernly, et al.
Advances in Clinical Chemistry|February 25, 2019
Clinical implications of fetuin-APeter Jirak, Lars Stechemesser, Elena Moré, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|November 2, 2021
The differential diagnostic value of selected cardiovascular biomarkers in Takotsubo syndromeAlbert Topf, Moritz Mirna, Vera Paar, et al.
European Journal of Internal Medicine|November 16, 2020
Serum levels of C-terminal FGF23 (cFGF23) are associated with 1-year-mortality in patients undergoing transcatheter aortic valve replacement (TAVR)Moritz Mirna, Alexander Lauten, Peter Jirak, et al.
Cardiovascular Research|January 23, 2021
A new player in the game: treatment with antagomiR-21a-5p significantly attenuates histological and echocardiographic effects of experimental autoimmune myocarditisMoritz Mirna, Vera Paar, Albert Topf, et al.
Panminerva Medica|April 21, 2020
Novel cardiovascular biomarkers in patients with cardiovascular diseases undergoing intensive physical exerciseMoritz Mirna, Michael Lichtenauer, Bernhard Wernly, et al.
Cells|November 11, 2022
Cell-Free Double-Stranded DNA to DNase Ratio Predicts Outcome after Primary Survived Cardiac ArrestRichard Rezar, Michael Lichtenauer, Vera Paar, et al.
Cells|October 13, 2023
MicroRNA-30d-5p-A Potential New Therapeutic Target for Prevention of Ischemic Cardiomyopathy after Myocardial InfarctionElke Boxhammer, Vera Paar, Bernhard Wernly, et al.
Frontiers in Medicine|February 21, 2022
Dexamethasone Improves Cardiovascular Outcomes in Critically Ill COVID-19, a Real World Scenario Multicenter AnalysisPeter Jirak, Vincent van Almsick, Dimitrios Dimitroulis, et al.
Frontiers in Cardiovascular Medicine|December 13, 2021
Higher Incidence of Stroke in Severe COVID-19 Is Not Associated With a Higher Burden of Arrhythmias: Comparison With Other Types of Severe PneumoniaPeter Jirak, Zornitsa Shomanova, Robert Larbig, et al.
Pageof 6